Glenmede Trust CO Na Abb Vie Inc. Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Abb Vie Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 460,839 shares of ABBV stock, worth $78.2 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

460,839

Previous 462,200 0.29%

Holding current value

$78.2 Million

Previous $79.3 Million 14.8%

% of portfolio

0.44%

Previous 0.41%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $222,986 - $271,288	-1,361 Reduced 0.29%	460,839 $91 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $529,227 - $618,018	-3,419 Reduced 0.73%	462,200 $79.3 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $16.1 Million - $18.4 Million	-100,887 Reduced 17.81%	465,619 $84.8 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $16.6 Million - $18.7 Million	120,563 Added 27.04%	566,506 $87.8 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $2.25 Million - $2.61 Million	16,850 Added 3.93%	445,943 $66.5 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $591,310 - $680,982	-4,089 Reduced 0.94%	429,093 $68.4 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $1.86 Million - $2.23 Million	-13,444 Reduced 3.01%	433,182 $70 Million
Q3 2022 Nov 16, 2022	BUY	$134.21 - $153.93 $324,385 - $372,048	2,417 Added 0.54%	446,626 $59.9 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $673,925 - $856,779	-4,897 Reduced 1.09%	444,209 $68 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $834,377 - $1.04 Million	-6,322 Reduced 1.39%	449,106 $72.8 Million
Q4 2021 Feb 15, 2022	SELL	$107.43 - $135.93 $1.3 Million - $1.65 Million	-12,133 Reduced 2.59%	455,428 $61.7 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $429,004 - $486,984	-4,032 Reduced 0.85%	467,561 $50.4 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $956,569 - $1.07 Million	-9,092 Reduced 1.89%	471,593 $53.1 Million
Q1 2021 May 18, 2021	SELL	$102.3 - $112.62 $141,787 - $156,091	-1,386 Reduced 0.29%	480,685 $52 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $2.29 Million - $3.09 Million	-28,471 Reduced 5.58%	482,071 $51.7 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $46.2 Million - $54.2 Million	-537,348 Reduced 51.28%	510,542 $44.7 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $35.4 Million - $47.4 Million	483,003 Added 85.5%	1,047,890 $103 Million
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $384,669 - $481,303	-5,333 Reduced 0.94%	564,887 $50 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $706,068 - $848,896	-11,211 Reduced 1.93%	570,220 $43.2 Million
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $37.3 Million - $47.7 Million	-567,586 Reduced 49.4%	581,431 $42.3 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $631,622 - $743,388	-8,188 Reduced 0.71%	1,149,017 $92.6 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $2.5 Million - $3.08 Million	32,100 Added 2.85%	1,157,205 $107 Million
Q3 2018 Nov 15, 2018	SELL	$88.91 - $98.84 $51.7 Million - $57.5 Million	-581,419 Reduced 34.07%	1,125,105 $106 Million
Q2 2018 Aug 15, 2018	BUY	$89.78 - $106.23 $3.66 Million - $4.33 Million	40,805 Added 2.45%	1,706,524 $158 Million
Q4 2017 Feb 15, 2018	BUY	$89.56 - $98.21 $41.6 Million - $45.6 Million	464,650 Added 38.69%	1,665,719 $161 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $83.9 Million - $107 Million	1,201,069	1,201,069 $0

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Abb Vie Inc. Transaction History